Study of the ENDOPLY System for Weight Loss
Part of Hormones & metabolism clinical trials.
This trial tests a new device called the ENDOPLY system, which is placed inside the stomach through a tube in the mouth to help with weight loss. It is for people who have struggled with dieting and have a BMI between 30 and 40.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) must be between 30 and 40.
- You must be between 18 and 60 years old.
- You have tried to lose weight with diets before but have not been able to keep the weight off.
- You cannot have certain serious health conditions like heart disease, cancer, or liver failure.
- You cannot have had weight-loss surgery or an endoscopic weight-loss procedure in the past.
- If you are pregnant, planning to get pregnant, or have been pregnant recently, you cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a stomach procedure (endoscopy) to help people with obesity lose weight or control health problems linked to weight. You may be considered if other weight-loss efforts have not worked and surgery is not the best option for you.
This study compares two different endoscopic procedures (EndoZip and Apollo ESG) to help obese patients lose weight. Both are done through the mouth without cutting the skin, and the goal is to see which works better and is safer.
This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.
This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.
This trial tests a device placed in the intestine to help control blood sugar and support weight loss in people with type 2 diabetes and obesity. It may offer a new option for managing both conditions together.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.